Back
UiPath Vs. Nukkleus Industry Stock Comparison
Sell
33
PATH
UiPath
Last Price:
$12.74
Seasonality Move:
-1.3%
Sell
46
NUKK
Nukkleus
Last Price:
$53.50
Seasonality Move:
-21.57%
Sell
33
UiPath (PATH)
is a Sell
Is UiPath a Buy, Sell or Hold?
-
PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUKK Stock Price Chart
PATH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 38.06 | Sell |
Chaikin Money Flow: | -6609239 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.07 - 14.83) | Sell |
Bollinger Bands (100): | (11.81 - 13.73) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.39 | Buy |
Relative Strength Index (14 RSI): | 98.39 | Buy |
Chaikin Money Flow: | -3568214 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.5 - 19.56) | Buy |
Bollinger Bands (100): | (-3.7 - 10.22) | Buy |
PATH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.91 | Sell |
20-day SMA: | 14.28 | Sell |
50-day SMA: | 13.37 | Sell |
200-day SMA: | 15.06 | Sell |
8-day EMA: | 13.71 | Sell |
20-day EMA: | 13.92 | Sell |
50-day EMA: | 13.55 | Sell |
200-day EMA: | 14.7 | Sell |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.25 | Buy |
20-day SMA: | 7.09 | Buy |
50-day SMA: | 4.23 | Buy |
200-day SMA: | 4.61 | Buy |
8-day EMA: | 22.64 | Buy |
20-day EMA: | 11.49 | Buy |
50-day EMA: | 6.13 | Buy |
200-day EMA: | 11.49 | Buy |
UiPath Earnings Growth & PATH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.41 per share, and a decrease next year of $0.00 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
UiPath Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |